GASTRIC NEUROENDOCRINE CARCINOMA
Clinical trials for GASTRIC NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo combo tested against standard for rare, aggressive gut cancers
Disease control OngoingThis study is comparing two different chemotherapy combinations to see which works better for people with an advanced, aggressive type of neuroendocrine cancer that starts in the stomach, intestines, or pancreas and has spread. Patients are randomly assigned to receive either the…
Matched conditions: GASTRIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control many different types of rare, advanced cancers that have limited treatment options. It enrolled over 800 adults whose cancer progressed after standard therapy. The g…
Matched conditions: GASTRIC NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC